Extracellular Vesicles as Delivery Systems in Disease Therapy

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Extracellular vesicles (EVs)/exosomes are nanosized membrane-bound structures that are released by virtually all cells. EVs have attracted great attention in the scientific community since the discovery of their roles in cell-to-cell communication. EVs’ enclosed structure protects bioactive molecules from degradation in the extracellular space and targets specific tissues according to the topography of membrane proteins. Upon absorption by recipient cells, EV cargo can modify the transcription machinery and alter the cellular functions of these cells, playing a role in disease pathogenesis. EVs have been tested as the delivery system for the mRNA COVID-19 vaccine. Recently, different therapeutic strategies have been designed to use EVs as a delivery system for microRNAs and mRNA. In this review, we will focus on the exciting and various platforms related to using EVs as delivery vehicles, mainly in gene editing using CRISPR/Cas9, cancer therapy, drug delivery, and vaccines. We will also touch upon their roles in disease pathogenesis.
Funding Information
  • National Institutes of Health (R01HL162579, 5I01BX004870-03)
  • Miami VA Health System (R01HL162579, 5I01BX004870-03)
  • Miami Heart Research Institute (R01HL162579, 5I01BX004870-03)

This publication has 59 references indexed in Scilit: